FEATURED ARTICLES
Wanted: More Women For Clinical Trials
A new national survey from UPMC’s Center for Connected Medicine examines why women remain underrepresented in clinical trials. The research highlights key barriers such as fear of side effects, time and travel burdens, and limited awareness about how trials work. In a conversation with UPMC’s Nicole Ansani, we explore what sites and sponsors can do to make trials more accessible and appealing to women.
-
![Wouter feature image]( "Site-Centric First, Patient-Centric Always")
Site-Centric First, Patient-Centric AlwaysAt the 2026 SCOPE Summit, Boehringer Ingelheim’s Wouter Daniels argued that true patient centricity begins with site centricity. Daniels shared how Boehringer’s engagement efforts have accelerated studies by months and saved millions — proof that patient focus delivers measurable business and operational value.
-
![Tina-&-Elizabeth]( "Clinical Trials Need Fewer Barriers And More Humans")
Clinical Trials Need Fewer Barriers And More HumansAt the SCOPE Summit, Tina Karunaratne and Elizabeth Tabor discussed the gaps that still limit clinical trial access — from patient navigation and education to the need for real human support alongside AI tools. They also highlighted the importance of networking, professional visibility, and moving beyond conference talking points to actionable solutions that connect both patients and the people who make research possible.
-
![Father playing with child-GettyImages-1567083882]( "Time Is Lives: How Collaboration And Urgency Are Rewriting The Future Of Rare Disease")
Time Is Lives: How Collaboration And Urgency Are Rewriting The Future Of Rare DiseaseThe inflection point has arrived, says Rob Freishtat, MD, MPH. Understand how collaboration will rewrite how we think of rare disease clinical research.
SERVICES & PRODUCTS
Clinical trials are how new treatments move from the lab to the people who need them most. By joining a study, you’re not only accessing potential new therapies—you’re helping advance medicine for future generations.
Clear the path for global clinical trial participation with 24/7 live assistance and personalized patient support.
From our inception, Ergomed has been committed to enhancing the patient journey in clinical trials. Our unique Ergomed CARE™ approach revolutionizes trials by optimizing the patient experience. Designed to address and resolve issues proactively, this comprehensive approach supports and engages all stakeholders, leading to accelerated study start-up, improved patient recruitment and retention, and investigator engagement.
Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.
We work as a single provider to empower patient and site participation in clinical trials. Our Integrated Trial Services team is dedicated to creating partnerships with our Sponsor and CRO clients, building strategic and unique combinations of solutions to accelerate trial timelines.
By removing barriers, and bringing trials to patients where they live, we can expand the geographical reach of clinical research across the globe allowing more patients to participate. Our patient-centric delivery means we can create convenience and comfort working the schedule of the trial around the schedule of the patient and their family, not the other way around. This approach provides important access to medical care, enhances the inclusivity of clinical trials and advances drug development for all.